drugset / Trial / NCT07396909
A First-in-Human Single and Multiple Ascending Dose Study of MT-701
RandomizedSingle-groupTriple-blindTreatment
Summary
First-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single and multiple doses of MT-701 in healthy participants.
Timeline
- Start
- 2026-01-12
- Primary completion
- 2026-04-16
- Completion
- 2026-04-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MT-701 | Unknown | — | Intravenous |
Indications
No indication recorded.